Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003026661 | SCV003323608 | pathogenic | Anophthalmia-microphthalmia syndrome | 2022-03-04 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr43Argfs*8) in the OTX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OTX2 are known to be pathogenic (PMID: 15846561, 20486942, 22577225, 24167467). This variant has not been reported in the literature in individuals affected with OTX2-related conditions. For these reasons, this variant has been classified as Pathogenic. |